Skip to main content
Top
Published in: Neurocritical Care 3/2018

01-12-2018 | Neurocritical care through history

Metabolic Encephalopathy: Behind the Name

Author: Eelco F. M. Wijdicks

Published in: Neurocritical Care | Issue 3/2018

Login to get access

Abstract

Metabolic encephalopathy may be the most common diagnosis in consultative acute neurology. The origin of this term is not generally known but can be traced back. The term replaced more commonly used designations such as organic or functional. The term metabolic encephalopathy was originally linked to organ dysfunction but subsequently became more imprecise. When it expanded to include a large number of diseases, it evolved to “metabolic neuronal dysfunction” and soon could not be distinguished from “quiet delirium” and other designations. This vignette summarizes why the terminology has confused more than clarified but also why it will likely stay in the neurologist’s vernacular.
Literature
1.
2.
go back to reference Laureno R. Foundations for clinical neurology. 1st ed. New York: Oxford University Press; 2017.CrossRef Laureno R. Foundations for clinical neurology. 1st ed. New York: Oxford University Press; 2017.CrossRef
3.
go back to reference Eidelman LA, Putterman D, Putterman C, Sprung CL. The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA. 1996;275:470–3.CrossRef Eidelman LA, Putterman D, Putterman C, Sprung CL. The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA. 1996;275:470–3.CrossRef
4.
go back to reference Kafa IM, Bakirci S, Uysal M, Kurt MA. Alterations in the brain electrical activity in a rat model of sepsis-associated encephalopathy. Brain Res. 2010;1354:217–26.CrossRef Kafa IM, Bakirci S, Uysal M, Kurt MA. Alterations in the brain electrical activity in a rat model of sepsis-associated encephalopathy. Brain Res. 2010;1354:217–26.CrossRef
5.
go back to reference Lockwood AH. Metabolic encephalopathies: opportunities and challenges. J Cereb Blood Flow Metab. 1987;7:523–6.CrossRef Lockwood AH. Metabolic encephalopathies: opportunities and challenges. J Cereb Blood Flow Metab. 1987;7:523–6.CrossRef
6.
go back to reference Mahoney CA, Arieff AI. Uremic encephalopathies: clinical, biochemical, and experimental features. Am J Kidney Dis. 1982;2:324–36.CrossRef Mahoney CA, Arieff AI. Uremic encephalopathies: clinical, biochemical, and experimental features. Am J Kidney Dis. 1982;2:324–36.CrossRef
7.
go back to reference Pun BT, Ely EW. The importance of diagnosing and managing ICU delirium. Chest. 2007;132:624–36.CrossRef Pun BT, Ely EW. The importance of diagnosing and managing ICU delirium. Chest. 2007;132:624–36.CrossRef
8.
go back to reference Glaser GH. Metabolic encephalopathy in hepatic, renal and pulmonary disorders. Postgrad Med. 1960;27:611–9.CrossRef Glaser GH. Metabolic encephalopathy in hepatic, renal and pulmonary disorders. Postgrad Med. 1960;27:611–9.CrossRef
9.
go back to reference Fazekas JF. Pathologic physiology of cerebral dysfunction. Am J Med. 1958;25:89–96.CrossRef Fazekas JF. Pathologic physiology of cerebral dysfunction. Am J Med. 1958;25:89–96.CrossRef
10.
go back to reference Fazekas JF, Alman RW. Coma: biochemistry, physiology and therapeutic principles 1st eds. Springfield: Charles C. Thomas Publishers, Ltd.; 1962. Fazekas JF, Alman RW. Coma: biochemistry, physiology and therapeutic principles 1st eds. Springfield: Charles C. Thomas Publishers, Ltd.; 1962.
11.
go back to reference Plum F, Posner JB. Diagnosis of Stupor and Coma, vol. 1. Philadelphia: F. A. Davis; 1966. Plum F, Posner JB. Diagnosis of Stupor and Coma, vol. 1. Philadelphia: F. A. Davis; 1966.
12.
go back to reference Sherlock S. Pathogenesis and management of hepatic coma. Am J Med. 1958;24:805–13.CrossRef Sherlock S. Pathogenesis and management of hepatic coma. Am J Med. 1958;24:805–13.CrossRef
13.
go back to reference Fugate JE, Kalimullah EA, Hocker SE, Clark SL, Wijdicks EFM, Rabinstein AA. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy. Crit Care. 2013;17:R264.CrossRef Fugate JE, Kalimullah EA, Hocker SE, Clark SL, Wijdicks EFM, Rabinstein AA. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy. Crit Care. 2013;17:R264.CrossRef
14.
go back to reference Wijdicks EFM. Why you may need a neurologist to see a comatose patient in the ICU. Crit Care. 2016;20:193.CrossRef Wijdicks EFM. Why you may need a neurologist to see a comatose patient in the ICU. Crit Care. 2016;20:193.CrossRef
Metadata
Title
Metabolic Encephalopathy: Behind the Name
Author
Eelco F. M. Wijdicks
Publication date
01-12-2018
Publisher
Springer New York
Published in
Neurocritical Care / Issue 3/2018
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-017-0497-1

Other articles of this Issue 3/2018

Neurocritical Care 3/2018 Go to the issue